Navigation Links
China Feed Pigments Sector Examined by CCM in In-demand Market Research Report Published at MarketPublishers.com
Date:10/21/2013

London, UK (PRWEB) October 21, 2013

During the past several decades, the Chinese feed pigment industry has undergone a considerable transformation. The most obvious changes include a shift from synthetic products to natural ones as well as the prevalence of domestic players over overseas competitors. In spite of the negative influence of a bird flu pandemic, China's macro environment remains favourable for the development of the feed pigment industry. The national feed pigment market is characterized by a moderate level of competition.

Guangzhou Wisdom Bio-Technology, Guangzhou Tungyong Natural Pigments, Guangzhou Leader Bio-Technology, Qingdao ZRZY Bio-Technology and Guangzhou Juyuan Bio-Chem are among the top players of the Chinese feed pigment market.

In-demand market research report “Survey of Feed Pigments in China” worked out by Guangzhou CCM Information Science & Technology Co. Ltd (CCM) has been recently published by Market Publishers Ltd.

Report Details:

Title: Survey of Feed Pigments in China
Published: August, 2013
Pages: 182
Price:    US$ 13,500.00
http://marketpublishers.com/report/food/food_supplements/survey-of-feed-pigments-in-china.html    

The report provides an insightful guide to the Chinese feed pigments market, covering the five key market segments: capsanthin, lutein, apo-ester, canthaxanthin and astaxanthin. The research study describes the actual market state, contains production statistics, delves into the competitive landscape and reviews the major market players. The report presents Porter’s five forces analysis of the segments examined, includes a PEST analysis of the Chinese macro environment and a SWOT analysis of the two leading manufacturers.

Report Scope:

  •     Comprehensive overview of the Chinese feed pigments market.
  •     In-depth analysis of the five key market segments: capsanthin, lutein, apo-ester, canthaxanthin and astaxanthin.
  •     Description of the current situation in the market.
  •     Production statistics.
  •     Evaluation of the competitive pressure and review of the top companies operating in the local market.
  •     Porter’s five forces analysis.
  •     PEST analysis of the Chinese macro environment.
  •     SWOT analysis of two leading manufacturers.

More insightful research reports by the publisher can be found at CCM page.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11251938.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Biomaterials China News 1307 – New Research Available
2. Vitamin D3 Market in China and Global Regions 2013 Structure and Value Analysis in a New Research Study at DeepResearchReports.com
3. New Kantar Health Data Show Number of Newly Diagnosed Breast Cancer Patients in China Will Surpass U.S. by 2015
4. Cellars Wine Club Analyzes Documentary "Red Obsession" and Wine in China
5. Global & China Diagnostic Reagent Industry 2013 Development Trends in a New Research Study Available at DeepResearchReports.com
6. China MMR Vaccine Market 2013 Analysis and 2017 Forecasts in New Research Report at ChinaMarketResearchReports.com
7. The Changing Face of Cervical Cancer in China
8. China Varicella Vaccine Market Discussed in In-demand QYResearch Report Published at MarketPublishers.com
9. China Haemophilus Influenza B (HIB) Vaccine Market 2017 Forecasts in New Research Now Available at MarketReportsOnline.com
10. Perfume Industry Review of Natural & Synthetic Perfumes for Global & China Markets in a New Research Study Available at DeepResearchReports.com
11. China Non-Small Cell Lung Cancer Analysis & 2022 Forecasts in New Research Report at RnRMarketResearch.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: